SEC Form 4 · accession 0001518973-26-000007
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michel Lagarde
Officer — President and CEO · Director
Period of report
Sep 8, 2026
Accepted (ET)
Sep 10, 2026 · 3:40 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000105770
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $337.75 | Sep 8, 2026 | A | 13,879 | A | — | Sep 8, 2036 | Common Stock | 13,879 | 13,879 | D |
| Stock Option (Right to Buy)F1 | $337.75 | Sep 8, 2026 | A | 11,081 | A | — | Sep 8, 2036 | Common Stock | 11,081 | 11,081 | D |
| Stock Option (Right to Buy)F2 | $337.75 | Sep 8, 2026 | A | 12,088 | A | — | Sep 8, 2036 | Common Stock | 12,088 | 12,088 | D |
| Rst. Stock UnitF3,F1 | — | Sep 8, 2026 | A | 6,200 | A | — | — | Common Stock | 6,200 | 6,200 | D |
| Rst. Stock UnitF3,F1 | — | Sep 8, 2026 | A | 4,950 | A | — | — | Common Stock | 4,950 | 4,950 | D |
| Rst. Stock UnitF3,F2 | — | Sep 8, 2026 | A | 3,600 | A | — | — | Common Stock | 3,600 | 3,600 | D |
Explanation of responses
- F1This award vests in four equal annual installments beginning on September 8, 2027.
- F2This award cliff vests on September 8, 2031.
- F3Each restricted stock unit represents a contingent right to receive one share of WST common stock.